Abstract
This paper reviews the aetiology, prevalence and treatment of gynaecomastia. Gynaecomastia is a proliferation of male breast tissue apparently caused by alterations in the ratio of oestrogen:androgen levels. It is common in the general population, resulting from normal physiological changes and various pathological causes. Gynaecomastia is also induced by many drug treatments, including hormonal therapies for prostate cancer. Prophylactic radiotherapy appears to be effective against gynaecomastia in this population. Surgery is an option for intractable cases, and some medical treatments have been reported, although there is a paucity of data evaluating such therapies.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tyrrell, C. Gynaecomastia: aetiology and treatment options. Prostate Cancer Prostatic Dis 2, 167–171 (1999). https://doi.org/10.1038/sj.pcan.4500314
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500314
- Springer Nature Limited
Keywords
This article is cited by
-
Profylactische tepelbestraling bij bicalutamidegebruik vanwege prostaatkanker: klinische noodzaak?
Tijdschrift voor Urologie (2014)
-
Gynecomastia in patients with prostate cancer: update on treatment options
Prostate Cancer and Prostatic Diseases (2006)